With heavy hearts, we announce the passing of co-founder Nolan Williams. He brought profound hope to so many. Nolan’s commitment to helping others will remain at the heart of what we do at Magnus, and we honor his memory and legacy by continuing the work he cared so deeply about.

New study with Magnus CSO Brandon Bentzley as Sr. Author shows rTMS for TRD leads to:​ ​ -24% fewer hospital stays -48% fewer ER visits -$893/pt reduction in overall episode-of-care costs​ In summary: rTMS works - and saves Read more: https://t.co/IdIvYSLtU3 #rTMS #MentalHealth

We’re headed to #CTMSS2025 in San Diego! Find Magnus Medical and #SAINT®: 📍 Booth #404 – June 12–14 🧠 PULSES Training – June 11–12 🎙️ FACTMS Event w/ Dr. Nolan Williams – June 12 Live demos. Real breakthroughs. DM us to schedule a meeting while you're at the conference! #TMS

Join us at booth #2126 at the American Psychiatric Association (APA) Meeting to learn more about SAINT®: the only FDA-cleared MRI-guided, rapid-acting brain stimulation therapy for depression. #APA2025 #APA #SAINT

This #MentalHealthAwarenessMonth, we’re proud to be part of a movement transforming lives through innovation, compassion and science. Thank you to our colleagues, partners & patients for inspiring us every day. #MagnusMedical #SAINT #MDD #Majordepression

Data presented at SOBP shows adolescents with moderate treatment-resistant depression treated with SAINT® therapy experienced significant antidepressant response and decreased suicidal ideation immediately post-treatment. Congratulations to all collaborators! #SOBP #SOBP2025 #TMS

At Magnus, we believe that every story matters and that progress in science and compassion go hand in hand. This month, let’s break the stigma, encourage open conversations, and work toward a future where everyone has access to the care they deserve. #mentalhealthawarenessmonth

Dr. Nolan Williams presents "Breakthrough Rapid-Acting Therapeutics: Exploring Efficacy and Mechanisms in Treatment-Resistant Mood Disorders" at the International Mental Health Research Symposium. https://t.co/eVxwPuxBiz #MDD #majordepression @NolanRyWilliams @BBRFoundation

We appreciate @PsychTimes for featuring SAINT® therapy in an article examining treatment for bipolar I depression.​ https://t.co/zsR5iSKgAv​ @NolanRyWilliams @BrandonBentzley #BipolarDisorder #iTBS #neuromodulation #SAINT

"She went from a blank stare, to eating, to actually smiling – all in one day." CBS Sunday morning features the SAINT® neuromodulation system for major depressive disorder:

ABC7 News segment discusses the difference between #TMS and #SAINT® for #majordepressivedisorder:

Attending #ADAA? Stop by booth 301 to learn more about the SAINT® neuromodulation system, a groundbreaking, rapid-acting therapy for treatment-resistant major depressive disorder (MDD). @ADAA_Anxiety #ADAA2025

Recent article in Brain Stimulation article discusses SAINT® as a personalized continuation therapy for depression: https://t.co/o7cUAGP8Il #SAINT #mentalhealth #brainstimulation #neuromodulation

Article discusses early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression: https://t.co/SAOl5Vt28m

Neuro Wellness Centers of America has introduced SAINT TMS therapy, an "innovative approach that many feel is revolutionizing treatment-resistant depression.​" ccording to Matthew Lahn, SAINT "represents the next frontier in #TMS." https://t.co/x3846qqTZW

Dr. Mohammed Ahmed, Dr. Nolan Williams, and Dr. Robert Neborsky sit down to discuss their collaboration in treating a mutual patient who received the SAINT® neuromodulation system at Kaizen Brain Center. @KaizenBrainCtr https://t.co/oSXNM8Mf2X

Study finds that SAINT® has shown preliminary feasibility, safety, tolerability, and efficacy in treating treatment-resistant bipolar I depression in 2-site open-label trial: https://t.co/FSFj1ZAoqT

Brandon Bentzley, MD, PhD presented "Magnus Neuromodulation System with SAINT as a Personalized Continuation Therapy for Depression: An Open-Label Pilot Trial" during a Symposium chaired by Nolan Williams, MD at the International Brain Stimulation Conference in Kobe, Japan.

Exciting news! Magnus Medical is officially on #YouTube! Subscribe to our channel for exclusive content, expert insights, and more: https://t.co/TrvLQZxNnx

Psychiatric Research Institute's Dr. Amy Grooms talks about the SAINT® neuromodulation system in a recent interview on KTHV-TV, Channel 11. Watch the full interview here: